Glucagon-like peptide 1 enhances glucose tolerance both by stimulation of insulin release and by increasing insulin-independent glucose disposal.
Glucagon-like peptide 1 [7-36 amide] (GLP-1) has been shown to enhance insulin secretion in healthy and type II diabetic humans, and to increase glucose disposal in type I diabetic patients. To further define its action on glucose kinetics, we studied six healthy subjects who received either GLP-1 (...
Sparad:
| I publikationen: | J Clin Invest |
|---|---|
| Huvudupphov: | , , , |
| Materialtyp: | Artigo |
| Språk: | Inglês |
| Utgiven: |
American Society for Clinical Investigation
1994
|
| Ämnen: | |
| Länkar: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC294382/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/8182159/ https://ncbi.nlm.nih.govhttps://doi.org/10.1172/JCI117225 |
| Taggar: |
Inga taggar, Lägg till första taggen!
|